Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen
...
Published in OncoImmunology
Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen
...
Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-...
Published in OncoImmunology
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
...
Published in OncoImmunology
Characteristics of tertiary lymphoid structures in primary cancers
Published in OncoImmunology
Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy
...
Published in OncoImmunology
Trial Watch: Monoclonal antibodies in cancer therapy
Published in OncoImmunology
Trial Watch-Oncolytic viruses and cancer therapy.
...Published in Oncoimmunology
Oncolytic virotherapy relies on the administration of non-pathogenic viral strains that selectively infect and kill malignant cells while favoring the elicitation of a therapeutically relevant tumor-targeting immune response. During the past few years, great efforts have been dedicated to the development of oncolytic viruses with improved specifici...
Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
...
Published in OncoImmunology
Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses
Published in OncoImmunology
An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy
Published in OncoImmunology
